{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T14:26:38Z","timestamp":1793456798352,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000633","name":"Humane Slaughter Association","doi-asserted-by":"publisher","award":["201306-05"],"award-info":[{"award-number":["201306-05"]}],"id":[{"id":"10.13039\/501100000633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","award":["H19H6a0026"],"award-info":[{"award-number":["H19H6a0026"]}],"id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jcyt.2021.12.003","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T00:42:12Z","timestamp":1644885732000},"page":"711-719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Mechanism for the attenuation of neutrophil and complement hyperactivity by MSC exosomes"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3492-7165","authenticated-orcid":false,"given":"Jia Tong","family":"Loh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7474-9482","authenticated-orcid":false,"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joey Kay Hui","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4636-8535","authenticated-orcid":false,"given":"Ruenn Chai","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9648-0755","authenticated-orcid":false,"given":"Andre Boon Hwa","family":"Choo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1316-4333","authenticated-orcid":false,"given":"Kong-Peng","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Kiang","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2021.12.003_bib0001","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jcyt.2020.05.002","volume":"22","author":"B\u00f6rger","year":"2020","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0002","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s13577-020-00407-w","article-title":"Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective","volume":"33","author":"Gupta","year":"2020","journal-title":"Human Cell"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0003","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12967-021-02884-5","article-title":"Exosomes contribution in COVID-19 patients\u2019 treatment","volume":"19","author":"Mazini","year":"2021","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0004","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S2213-2600(20)30404-5","article-title":"Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes","volume":"8","author":"Leisman","year":"2020","journal-title":"The Lancet Respiratory Medicine"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0005","doi-asserted-by":"crossref","first-page":"e754","DOI":"10.1016\/S2665-9913(20)30343-X","article-title":"Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study","volume":"2","author":"Webb","year":"2020","journal-title":"The Lancet Rheumatology"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0006","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/S2666-5247(20)30223-8","article-title":"COVID-19 cytokine storm syndrome: a threshold concept","volume":"2","author":"Chen","year":"2021","journal-title":"The Lancet Microbe"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0007","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.140289","article-title":"Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis","volume":"5","author":"Wilson","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0008","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41577-019-0168-x","article-title":"New insights into the immune functions of complement","volume":"19","author":"Reis","year":"2019","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0009","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/cr.2009.139","article-title":"Complement and its role in innate and adaptive immune responses","volume":"20","author":"Dunkelberger","year":"2010","journal-title":"Cell Research"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0010","doi-asserted-by":"crossref","first-page":"eabh2259","DOI":"10.1126\/sciimmunol.abh2259","article-title":"Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection","volume":"6","author":"Ma","year":"2021","journal-title":"Science Immunology"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0011","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.140711","article-title":"The complement system in COVID-19: friend and foe?","volume":"5","author":"Java","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0012","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41577-020-0320-7","article-title":"Complement as a target in COVID-19?","volume":"20","author":"Risitano","year":"2020","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases","volume":"220","author":"Magro","year":"2020","journal-title":"Translational Research\u00a0: The Journal of Laboratory and Clinical Medicine"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0014","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1182\/blood.2020008248","article-title":"Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition","volume":"136","author":"Yu","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0015","doi-asserted-by":"crossref","first-page":"25018","DOI":"10.1073\/pnas.2010540117","article-title":"Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients","volume":"117","author":"Holter","year":"2020","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0016","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00430-021-00704-7","article-title":"An update: the emerging evidence of complement involvement in COVID-19","volume":"210","author":"Li","year":"2021","journal-title":"Medical Microbiology and Immunology"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0017","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41586-020-2600-6","article-title":"Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis","volume":"588","author":"Carvelli","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0018","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1164\/rccm.202007-2778LE","article-title":"Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19","volume":"202","author":"Zelek","year":"2020","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100590","article-title":"Eculizumab as an emergency treatment for adult patients with severe COVID-19 in the intensive care unit: A proof-of-concept study","volume":"28","author":"Annane","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0020","doi-asserted-by":"crossref","first-page":"e764","DOI":"10.1016\/S2665-9913(20)30341-6","article-title":"Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial","volume":"2","author":"Vlaar","year":"2020","journal-title":"The Lancet Rheumatology"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108450","article-title":"The first case of COVID-19 treated with the complement C3 inhibitor AMY-101","volume":"215","author":"Mastaglio","year":"2020","journal-title":"Clinical Immunology (Orlando, Fla)"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0022","doi-asserted-by":"crossref","DOI":"10.1038\/s41418-021-00805-z","article-title":"Patients with COVID-19: in the dark-NETs of neutrophils","author":"Ackermann","year":"2021","journal-title":"Cell Death & Differentiation"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0023","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201129","article-title":"SARS-CoV-2\u2013triggered neutrophil extracellular traps mediate COVID-19 pathologySARS-CoV-2 directly triggers ACE-dependent NETs","volume":"217","author":"Veras","year":"2020","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0024","article-title":"Neutrophil extracellular traps in COVID-19","volume":"5","author":"Zuo","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.652470","article-title":"Neutrophils in COVID-19","volume":"12","author":"Reusch","year":"2021","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0026","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.3389\/fimmu.2021.680134","article-title":"Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets","volume":"12","author":"Hazeldine","year":"2021","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0027","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1182\/bloodadvances.2020003568","article-title":"A neutrophil activation signature predicts critical illness and mortality in COVID-19","volume":"5","author":"Meizlish","year":"2021","journal-title":"Blood Advances"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102711","article-title":"CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death","volume":"24","author":"L\u00e9vy","year":"2021","journal-title":"IScience"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0029","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.4049\/jimmunol.1301410","article-title":"Complement Component C5 Recruits Neutrophils in the Absence of C3 during Respiratory Infection with Modified Vaccinia Virus Ankara","volume":"194","author":"Price","year":"2015","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0030","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3389\/fcell.2021.624025","article-title":"Complement Receptors and Their Role in Leukocyte Recruitment and Phagocytosis","volume":"9","author":"Vandendriessche","year":"2021","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0031","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/infdis\/jiaa789","article-title":"Fostamatinib Inhibits Neutrophils Extracellular Traps Induced by COVID-19 Patient Plasma: A Potential Therapeutic","volume":"223","author":"Strich","year":"2021","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0032","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1021\/acscentsci.0c01669","article-title":"Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19","volume":"7","author":"Delaveris","year":"2021","journal-title":"ACS Central Science"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0033","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.cell.2020.08.002","article-title":"Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19","volume":"182","author":"Silvin","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0034","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/1744666X.2021.1905526","article-title":"Circulating Calprotectin as a Biomarker of COVID-19 Severity","volume":"17","author":"Mahler","year":"2021","journal-title":"Expert Review of Clinical Immunology"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0035","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.chom.2020.12.016","article-title":"Induction of alarmin S100A8\/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19","volume":"29","author":"Guo","year":"2021","journal-title":"Cell Host & Microbe"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0036","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41577-020-0328-z","article-title":"COVID-19: a case for inhibiting IL-17?","volume":"20","author":"Pacha","year":"2020","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0037","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2147\/JIR.S278335","article-title":"Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy","volume":"13","author":"Shibabaw","year":"2020","journal-title":"Journal of Inflammation Research"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0038","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jmii.2020.03.005","article-title":"TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib","volume":"53","author":"Wu","year":"2020","journal-title":"Journal of Microbiology, Immunology and Infection"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0039","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1089\/scd.2013.0479","article-title":"Mesenchymal Stem Cells Secrete Immunologically Active Exosomes","volume":"23","author":"Zhang","year":"2013","journal-title":"Stem Cells and Development"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0040","doi-asserted-by":"crossref","first-page":"21637","DOI":"10.1016\/S0021-9258(19)36659-1","article-title":"Differential stimulation of protein kinase C activity by phorbol ester or calcium\/phosphatidylserine in vitro and in intact synaptosomes","volume":"267","author":"Robinson","year":"1992","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0041","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-1-62703-200-1_3","article-title":"Mesenchymal stem cell exosomes: the future MSC-based therapy?","author":"Lai","year":"2013","journal-title":"Mesenchymal stem cell therapy"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0042","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.kint.2020.05.013","article-title":"The case of complement activation in COVID-19 multiorgan impact","volume":"98","author":"Noris","year":"2020","journal-title":"Kidney International"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0043","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12931-020-01428-7","article-title":"Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19","volume":"21","author":"Ye","year":"2020","journal-title":"Respiratory Research"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0044","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1182\/blood.2020007008","article-title":"Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome","volume":"136","author":"Middleton","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0045","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1172\/JCI141374","article-title":"Complement and tissue factor\u2013enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis","volume":"130","author":"Skendros","year":"2020","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0046","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s12016-020-08804-7","article-title":"A Review of Neutrophil Extracellular Traps (NETs) in Disease: Potential Anti-NETs Therapeutics","volume":"61","author":"Mutua","year":"2021","journal-title":"Clinical Reviews in Allergy & Immunology"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0047","first-page":"2689","article-title":"Neutrophil extracellular traps: double-edged swords of innate immunity","volume":"189","author":"Kaplan","year":"2012","journal-title":"Journal of Immunology (Baltimore, Md\u00a0: 1950)"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0048","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1042\/BST20180079","article-title":"MSC exosome works through a protein-based mechanism of action","volume":"46","author":"Toh","year":"2018","journal-title":"Biochemical Society Transactions"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0049","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1479-5876-9-47","article-title":"Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs","volume":"9","author":"Chen","year":"2011","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0050","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.scr.2009.12.003","article-title":"Exosome secreted by MSC reduces myocardial ischemia\/reperfusion injury","volume":"4","author":"Lai","year":"2010","journal-title":"Stem Cell Research"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0051","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.yjmcc.2009.12.021","article-title":"Derivation and characterization of human fetal MSCs: an alternative cell source for large-scale production of cardioprotective microparticles","volume":"48","author":"Lai","year":"2010","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0052","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1074\/mcp.M600393-MCP200","article-title":"Elucidating the secretion proteome of human embryonic stem cell-derived mesenchymal stem cells","volume":"6","author":"Sze","year":"2007","journal-title":"Molecular & Cellular Proteomics"},{"issue":"12","key":"10.1016\/j.jcyt.2021.12.003_bib0053","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.joca.2016.06.022","article-title":"Exosomes derived from human embryonic mesenchymal stem cells promote osteochondral regeneration","volume":"24","author":"Zhang","year":"2016","journal-title":"Osteoarthritis and Cartilage"},{"key":"10.1016\/j.jcyt.2021.12.003_bib0054","article-title":"Extracellular vesicles derived from mesenchymal stromal cells mitigate intestinal toxicity in a mouse model of acute radiation syndrome","volume":"371","author":"Accarie","year":"2020","journal-title":"Stem Cell Research & Therapy"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324922000184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324922000184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:42:56Z","timestamp":1778812976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324922000184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":54,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1465324922000184"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2021.12.003","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism for the attenuation of neutrophil and complement hyperactivity by MSC exosomes","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2021.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society for Cell & Gene Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}